|
private:xrapid
|
3765979
|
Jun 4th, 2019 12:00AM
|
xRapid Foundation
|
197
|
1.00
|
Open
|
Biotechnology
|
Jun 4th, 2019 03:14PM
|
Jun 4th, 2019 03:14PM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
Open
|
Health Technology, Malaria Diagnostics, Diagnostic Technology, Malaria Diagnostic App, Malaria, Smartphone Diagnosis, Malaria Blog, Digital Microscopy, Automated Malaria Diagnosis, Automated Digital Microscopy
|
Open
|
North Road
|
London
|
Greater London
|
GB
|
N79D
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Mar 18th, 2018 12:00AM
|
xRapid-Medical
|
170
|
6.00
|
Open
|
Biotechnology
|
Mar 18th, 2018 06:41PM
|
Mar 18th, 2018 06:41PM
|
|
Open
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 17th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 16th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 15th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 14th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 13th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 12th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 11th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|
|
private:xrapid
|
3765979
|
Feb 10th, 2018 12:00AM
|
xRapid-Medical
|
166
|
9.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease.
By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market.
The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease.
xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster.
Story:
xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
|
|
|
|
|
|
|
|
|
|
xRAPID
|
|
|